News

  • 2018/08

    Obtained EU CE Certification「BL-Cart™ IOL Delivery Cartridge」

  • 2018/07

    ICARES(6612-TW) IPO listed at TPEX on 2018.07.18

  • 2018/07

    Obtained the NHI Code of 「aspicio™ Preloaded IOL Delivery System」

  • 2018/06

    LubriMATRIX obtained US patent US 10,005,854 B2 (Actual patent number to be issued) FUNCTIONALIZED HYDROPHILIC AND LUBRICIOUS POLYMERIC MATRIX AND METHODS OF USING SAME

  • 2018/05

    Obtained TFDA approval of「”ICARES” IOL Delivery System」

  • 2017/12

    Obtained TFDA approval of「aspicio™ Preloaded IOL Delivery System」

  • 2017/12

    Obtained US FDA 510(k) clearance of「pioli™ IOL Delivery System」

  • 2017/08

    Obtained EU CE Certification「pioli™ IOL Delivery System」

  • 2017/04

    Obtained EU CE Certification「Asqelio ™ Soft Hydrophobic Intraocular Lens」

  • 2016/07

    Completed prototyping of Toric IOL

  • 2016/07

    Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs

  • 2015/11

    「aspicio™ Soft Hydrophobic Intraocular Lens」has obtained the NHI Code from the National Health Insurance Administration Ministry of Health and Welfare

  • 2015/07

    Enterprise Resource Planning (ERP) has been implement

  • 2015/07

    Obtained Vietnam approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」

  • 2015/06

    Obtained TFDA approval of 「aspicio™ Soft Hydrophobic Intraocular Lens」

  • 2015/04

    First order of IOLs selling to the global market

  • 2015/04

    Completed the acquisition of 100% AST Products, Inc. ( a US corporation) as our marketing and strategic partner

  • 2015/04

    Obtained US FDA 510(k) clearance of「lioli™ IOL Delivery System」

  • 2015/03

    Obtained TFDA approval of「lioli™ IOL Delivery System」

  • 2015/02

    Applied US patent for「INJECTOR BARREL AND PLUNGER」

  • 2014/11

    Obtained CE Mark approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」

  • 2014/07

    Obtained GMP certification for the manufacturing facility via TFDA

  • 2013/11

    Completed prototyping of IOL and its delivery system

  • 2013/06

    Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs

  • 2013/04

    Obtained certification of ISO 9001/13485 Quality Management Systems

  • 2012/10

    Received supplementary for the project of 「Development of High Value Aspheric Intraocular Lens and Its Delivery System for Cataract Surgery」from the Ministry of Economic Affairs

  • 2012/09

    IOL manufacturing technology successfully transferred from MBI (Millennium Biomedical, Inc., USA)

  • 2012/06

    Received a grant from the R&D Piloting Cooperation Projects between Industries and Academia at the Hsinchu Science Park for the project of 「Development of novel drug eluting intraocular lens」

  • 2012/06

    Approved as a biotech and pharma company officially by the Ministry of Economic Affairs

  • 2012/02

    Granted certificate from the Public Health Bureau to manufacture medical devices

  • 2012/01

    Granted factory registration certificate from the Public Health Bureau

  • 2011/09

    Granted certificate from the Public Health Bureau to sell medical devices

  • 2011/07

    Founded in Hsinchu, Taiwan, ICARES mainly focuses on development and selling of Intraocular Lens (IOL), IOL Delivery System, and medical devices applied to ophthalmic and nanotechnology fields